Maravai Lifesciences Holdings, Inc. (MRVI)
7.405
-0.14
(-1.79%)
USD |
NASDAQ |
Nov 16, 16:00
7.405
0.00 (0.00%)
After-Hours: 19:26
Maravai Lifesciences Holdings Enterprise Value : 1.374B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.374B |
| November 12, 2026 | 1.395B |
| November 11, 2026 | 1.397B |
| November 10, 2026 | 1.421B |
| November 09, 2026 | 1.445B |
| November 06, 2026 | 1.371B |
| November 05, 2026 | 1.290B |
| November 04, 2026 | 1.400B |
| November 03, 2026 | 1.360B |
| November 02, 2026 | 1.321B |
| October 30, 2026 | 1.414B |
| October 29, 2026 | 1.511B |
| October 28, 2026 | 1.517B |
| October 27, 2026 | 1.481B |
| October 26, 2026 | 1.380B |
| October 23, 2026 | 1.341B |
| October 22, 2026 | 1.303B |
| October 21, 2026 | 1.378B |
| October 20, 2026 | 1.323B |
| October 19, 2026 | 1.292B |
| October 16, 2026 | 1.262B |
| October 15, 2026 | 1.303B |
| October 14, 2026 | 1.226B |
| October 13, 2026 | 1.223B |
| October 12, 2026 | 1.302B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.359B |
| October 08, 2026 | 1.324B |
| October 07, 2026 | 1.357B |
| October 06, 2026 | 1.420B |
| October 05, 2026 | 1.520B |
| October 02, 2026 | 1.427B |
| October 01, 2026 | 1.368B |
| September 30, 2026 | 1.392B |
| September 29, 2026 | 1.396B |
| September 28, 2026 | 1.393B |
| September 25, 2026 | 1.389B |
| September 24, 2026 | 1.396B |
| September 23, 2026 | 1.354B |
| September 22, 2026 | 1.368B |
| September 21, 2026 | 1.325B |
| September 18, 2026 | 1.295B |
| September 17, 2026 | 1.339B |
| September 16, 2026 | 1.275B |
| September 15, 2026 | 1.281B |
| September 14, 2026 | 1.252B |
| September 11, 2026 | 1.229B |
| September 10, 2026 | 1.259B |
| September 09, 2026 | 1.292B |
| September 08, 2026 | 1.328B |
| September 04, 2026 | 1.347B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 51.24B |
| Bio-Rad Laboratories, Inc. | 9.549B |
| Bruker Corp. | 11.01B |
| Azenta, Inc. | 1.625B |
| Danaher Corp. | 186.02B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.00M |
| Revenue (Quarterly) | 45.85M |
| Total Expenses (Quarterly) | 59.69M |
| EPS Diluted (Quarterly) | -0.0928 |
| Gross Profit Margin (Quarterly) | 35.31% |
| Profit Margin (Quarterly) | -52.34% |
| Earnings Yield | -6.05% |
| Normalized Earnings Yield | -1.942 |